**Conflict of interest**

The authors declare that there is no conflict of interest.

PRESS spectra point-resolved spectroscopy

Rb retinoblastoma

TP53 tumor protein

TE echo time

wt wild type

**Author details**

Cluj-Napoca, Romania

Cluj-Napoca, Romania

10.1111/bpa.12171

10.1007/s00401-014-1370-3

**References**

Pharmacy, Cluj-Napoca, Romania

PTEN phosphatase and tensin homolog

TERT telomerase reverse transcriptase

Ștefan Ioan Florian1,2 and Sergiu Șuşman3,4\*

VEGFA vascular endothelial growth factor A

\*Address all correspondence to: sergiu.susman@umfcluj.ro

1 Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy,

Diffuse Astrocytoma and Oligodendroglioma: An Integrated Diagnosis and Management

http://dx.doi.org/10.5772/intechopen.76205

133

3 Department of Morphological Sciences, Iuliu Hațieganu University of Medicine and

[1] Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the

[2] Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, et al. International society of neuropathology—Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathology. 2014;**24**(5):429-435. DOI:

[3] Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, et al. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathologica. 2015;**129**(1):133-146. DOI:

4 Pathology Department, Division of Neuropathology, IMOGEN Research Center,

Central Nervous System. 4th ed. Lyon: IARC Press; 2016

2 Clinic of Neurosurgery, County Emergency Hospital, Cluj-Napoca, Romania
